Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach


Creative Commons License

Broer S. L., van Disseldorp J., Broeze K. A., Dolleman M., Opmeer B. C., Bossuyt P., ...Daha Fazla

HUMAN REPRODUCTION UPDATE, cilt.19, sa.1, ss.26-36, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1093/humupd/dms041
  • Dergi Adı: HUMAN REPRODUCTION UPDATE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.26-36
  • Anahtar Kelimeler: ovarian reserve tests, AMH, AFC, individual patient data meta-analysis, IVF outcome prediction, FOLLICLE-STIMULATING-HORMONE, ANTI-MULLERIAN HORMONE, IN-VITRO FERTILIZATION, RANDOMIZED CLINICAL-TRIAL, BASAL FSH CONCENTRATION, ANTIMULLERIAN HORMONE, INHIBIN-B, LIVE-BIRTH, IVF TREATMENT, DATA METAANALYSIS
  • Gazi Üniversitesi Adresli: Evet

Özet

Although ovarian reserve tests (ORTs) are frequently used prior to IVF treatment for outcome prediction, their added predictive value is unclear. We assessed the added value of ORTs to patient characteristics in the prediction of IVF outcome.